Navigation Links
Cognitively-impaired human research subjects need better protection
Date:12/7/2010

(Garrison, NY) Practices for protecting human research subjects with Alzheimer's disease and other conditions that make them incapable of giving informed consent are widely variable and in need of more concrete ethical and legal guidance, according to a study in IRB: Ethics & Human Research.

The findings are significant for several reasons. First of all, the authors write, many countries have made research on dementia a national health priority and launched clinical trials that involve people who are, or are likely to become, cognitively impaired. These trials increasingly involve invasive interventions which may pose more than minimal risk. And yet throughout the world, regulations and guidelines provide little direction to ethics review committees about how best to protect these people and about who can make decisions on their behalf.

The new study, part of a larger Canadian research program called Substitute Consent for Research in Elderly Subjects (SCORES), involved telephone interviews with 46 research ethics board chairs in Canada, assessing their attitudes toward enrolling in clinical trials older adults without decision-making capacity and asking what safeguards they would require. Twenty respondents said they had reviewed research protocols involving such persons during the past year and all allowed them to participate in research under certain conditions, such as minimal risks or consent from a substitute decision-maker.

More than half of the ethics board chairs said that they required additional protections for this population, such as assessing decisional capacity. "Yet the fact that some REBs [research ethics boards] did not require these additional safeguards is cause for concern," wrote the researchers. Four allowed older adults without decision-making capacity to part
'/>"/>

Contact: Michael Turton
turtonm@thehastingscenter.org
845-424-4040 x242
The Hastings Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Species Extinctions May Spell Trouble for Human Health
2. Experts urge US to create emergency cholera vaccine stockpile for humanitarian use
3. Female fish -- and humans? -- lose interest when their male loses a slugfest
4. To be or not to be? Public event examines question of human identity and consciousness
5. PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans
6. HFES announces Release of Reviews of Human Factors and Ergonomics, Volume 6
7. Rogue gene hijacks stem cells to jumpstart human cancer
8. Scientists Use Tarantulas to Explore Human Fear
9. Dangerous chemicals in food wrappers likely migrating to humans: U of T study
10. Early Humans More Advanced Than Thought
11. Wildlife health reporting tools may help prevent human illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... (PRWEB) March 28, 2015 With ... in the fields of osteoporosis, osteoarthritis and musculoskeletal ... Osteoporosis, it may be the first time in ... research forum that the hot-button topic is an ... on the well-accepted scientific principles of Wolff’s law, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
(Date:3/28/2015)... IL (PRWEB) March 28, 2015 Centurion Service ... equipment auction on Thursday, April 2 at their Las Vegas ... Vegas, NV 89081. The sale, which consists of equipment from ... begin promptly at 9 a.m. PDT. , Buyers will ... and surgery equipment. “We are a one-stop-shop,” said Erik Tivin, ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... the $60 billion international beauty products industry is ... a hundred cosmetics are in the Project on ... manufacturers as containing nanomaterials. , Critical to ... in their safety. In Europe, regulators and companies ...
... The rate of childhood,obesity in America has ... percent of children ages 10 to 17 are ... threat of the obesity epidemic for,children, families, communities ... a Healthy Florida ( http://www.bluefoundationfl.com ), the,philanthropic affiliate ...
... Joins 40 Others in Screening for Life-Threatening, Genetic,Disease, ... and the District of Columbia in requiring that all ... congratulate Alabama for initiating a newborn screening program for,cystic ... of the,Cystic Fibrosis Foundation. "More than 40 states are ...
... the Number of Women,s ... Medications Offered at a Discount, CINCINNATI, May 13 ... will expand their generic drug,program -- offering customers lower prices ... is offering 90-day prescriptions for,only $10 on its expanded generic ...
... Ancient acupuncture and modern myofascial pain therapy each focus ... treat pain, although they do it differently, says a ... two techniques. , Results of the study, published May ... suggest that people who want relief from chronic musculoskeletal ...
... New Retinoic Acid and Clindamycin Products Developed ... Skinvisible, Inc. (OTC,Bulletin Board: SKVI) ( ... on formulating enhanced patented dermatology,products, announced it ... Pharmaceutical Co. Ltd. ("Embil"). The Agreement is ...
Cached Medicine News:Health News:The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity 2Health News:Alabama Begins Mandatory Screening of Newborns for Cystic Fibrosis 2Health News:Kroger and Its Family of Stores Expand Discounted Generic Drug Program 2Health News:Kroger and Its Family of Stores Expand Discounted Generic Drug Program 3Health News:Mayo Clinic study shows acupuncture and myofascial trigger therapy treat same pain areas 2Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 2Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 3
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... March 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... of its previously announced registered offering of common shares ... "Offering"). Pursuant to the Offering, the Company issued 7,286,432 ... for aggregate gross proceeds of approximately $1.45 billion. On ... Securities and Exchange Commission a final prospectus supplement to ...
(Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... Nov. 4 CVS Caremark (NYSE: CVS ) ... position of SVP, Marketing for its pharmacy benefit management ... marketing from Jack Bruner, who is transitioning to the ... http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , Greer brings ...
... 4 Neuronascent, Inc., a privately-held biotechnology company ... of depression, Alzheimer,s disease, Parkinson,s and other neurodegenerative ... agreement with ChemRar Pharma, a Russian biotechnology start-up ... and stem cells to treat cancer. Under the ...
Cached Medicine Technology:Company Appoints New SVP, Marketing for PBM Business 2Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascent's Neurogenesis Platform 2
... Analyzer II is a ... to enumerate fluorescently labeled ... selected and aligned. The ... CellTracks® Analyzer II, a ...
... These unique Acid Fast ... sputum smear with appropriate background ... containing a positive and negative ... Kinyoun (Cat. No. 353), Ziehl-Neelsen ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Medicine Products: